{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:37:19Z","timestamp":1774730239475,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2006,8,21]],"date-time":"2006-08-21T00:00:00Z","timestamp":1156118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Laboratory technicians, laboratory supervisors, decontamination\/remediation workers, and environmental investigators are at increased risk for repeated occupational exposure to <jats:italic>Bacillus anthracis<\/jats:italic>. In 2002, the Advisory Committee on Immunization Practices (ACIP) recommended pre\u2010exposure vaccination for these occupational groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To determine (1) the factors that influenced an individual's decision to either accept or decline Anthrax Vaccine Adsorbed (AVA), and (2) if laboratory workers' concern about AVA safety was related to their information needs and trust in the information provided.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a decision\u2010making survey of 404 participants at 44 Laboratory Response Network laboratories located throughout the United States. All participants were enrolled between October 2002 and December 2004, and all were eligible to receive AVA according to the 2002 ACIP recommendations. Chi\u2010square tests and multivariate logistic regression were used in the analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The response rate of eligible individuals at participating laboratories was 94% (404\/430). Sixty\u2010six percent of respondents accepted and 34% declined AVA. Laboratory workers who declined AVA were more likely to rate their risk of exposure to inhalation anthrax as low (OR\u2009=\u20096.9; 95%CI 1.7, 28.3), report being very concerned (OR\u2009=\u20094.1; 95%CI 1.8, 9.3) or concerned (OR\u2009=\u20092.0; 95%CI 1.3, 3.1) about the safety of the vaccine, report that they did not trust the information provided in the Vaccine Information Statement (VIS) (OR\u2009=\u20092.3; 95%CI 1.1, 4.5), and to be enrolled in the study during 2002 (OR\u2009=\u200924.7; 95%CI 6.4, 95.3) or 2003 (OR\u2009=\u20095.0; 95%CI 2.5, 9.8), the first 2 years of the study. Furthermore, we found a significant association between a participant's level of concern about the safety of AVA and their perception that they received enough information and\/or trusted the information in the VIS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Low perceived necessity, concern about the safety of the vaccine, and a lack of trust in the VIS were associated with the decision of laboratory workers to decline AVA. Results of this decision\u2010making study may be used to try to improve acceptance rates of AVA among persons considered at high risk, and may inform educational efforts for other adult vaccines. Copyright \u00a9 2006 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.1302","type":"journal-article","created":{"date-parts":[[2006,8,21]],"date-time":"2006-08-21T15:46:22Z","timestamp":1156175182000},"page":"880-888","source":"Crossref","is-referenced-by-count":16,"title":["Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision\u2010making study in CDC's anthrax vaccination program"],"prefix":"10.1002","volume":"15","author":[{"given":"Gabrielle L.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Baggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey W.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Gust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,8,21]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0810.020353"},{"key":"e_1_2_1_3_2","unstructured":"SternbergS.Study says prompt treatment cut anthrax cases.USA Today3\u20108\u20102002."},{"key":"e_1_2_1_4_2","unstructured":"KaufmanM.U.S. awards anthrax vaccine deal.The Washington Post11\u20105\u20102004."},{"key":"e_1_2_1_5_2","unstructured":"Opinion and Editorials.Anthrax killer at large.The Washington Post12\u201015\u20102004."},{"key":"e_1_2_1_6_2","unstructured":"MartinezCapt.Kenneth F.Personal testimony before Congress: Capt. Kenneth F. Martinez MSEE CIH Supervisory Industrial Hygienist National Institute for Occupational Safety and Health Centers for Disease Control and Prevention Department of Health and Human Services on May 19 2003. The Committee on Government Reform Sub\u2010Committee on National Security Emerging Threats and International Relations. 5\u201019\u20102003."},{"key":"e_1_2_1_7_2","unstructured":"PopovicTanja.Personal testimony before Congress: Tanja Popovic M.D. Ph.D. Acting Associate Director for Science for CDC on April 5 2005. The Committee on Government Reform Subcommittee on National Security Emerging Threats and International Relations. 4\u20105\u20102005."},{"issue":"15","key":"e_1_2_1_8_2","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"Morb Mortal Wkly Rep"},{"issue":"45","key":"e_1_2_1_9_2","first-page":"1024","article-title":"Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.21236\/ADA403352"},{"key":"e_1_2_1_11_2","first-page":"45","volume-title":"Health Behavior and Health Education","author":"Janz NK","year":"2002"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200404000-00011"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-3-20"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/502147"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/502323"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/502146"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2003.tb00043.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.063"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.2002.1047"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.5.470"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2005.04.010"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1302","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.1302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T18:29:02Z","timestamp":1700072942000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,21]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1002\/pds.1302"],"URL":"https:\/\/doi.org\/10.1002\/pds.1302","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,21]]}}}